Bao, Y., Oguz, G., Lee, W., Lee, P., Ghosh, K., Li, J., . . . MEDICINE. (2021). EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy. Nature Research.
استشهاد بنمط شيكاغوBao, Y., et al. EZH2-mediated PP2A Inactivation Confers Resistance to HER2-targeted Breast Cancer Therapy. Nature Research, 2021.
MLA استشهادBao, Y., et al. EZH2-mediated PP2A Inactivation Confers Resistance to HER2-targeted Breast Cancer Therapy. Nature Research, 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.